Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Salute e medicinaOne-Off1a
Manifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoPrevisione della comunità attualeNo 77.9%
Previsori
14
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato 13 ore fa
Obsoleto21 feb 23, 20:23 UTC31 dic 27, 22:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of breast cancer before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against malaria before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegole
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
